• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病足感染中致病微生物的特征分析及风险预测模型的建立

Characterization of pathogenic microorganisms in diabetic foot infections and development of a risk prediction model.

作者信息

Yan Shufang, Zhu Xuemeng, Yu Tong, Li Dandan, Li Su, Xue Lei

机构信息

Department of Endocrinology, Henan University Huaihe Hospital, Kaifeng, 475500, Henan, China.

Department of Pathology, Henan University Huaihe Hospital, Kaifeng, Henan, China.

出版信息

Sci Rep. 2025 Jul 2;15(1):23553. doi: 10.1038/s41598-025-07092-5.

DOI:10.1038/s41598-025-07092-5
PMID:40604114
Abstract

This study aimed to investigate the distribution of pathogenic microorganisms in diabetic foot infections (DFIs) and develop a nomogram to predict DFIs. It included 136 diabetic foot (DF) patients hospitalized at Henan University Huaihe Hospital from November 2020 to November 2024, with 86 (63.23%) having confirmed infections. Infections were predominantly caused by Gram-positive cocci (54.65%) and Gram-negative bacilli (43.02%). The nomogram incorporated age, C-reactive protein (CRP), Wagner grade, lower extremity arterial disease (LEAD), and peripheral neuropathy (PN). The predictive model exhibited robust discriminatory capacity, achieving an area under the curve (AUC) of 0.803 (95% confidence interval (CI) 0.735-0.878) with internal cross-validation stability (AUC = 0.804). Goodness-of-fit was confirmed by the Hosmer-Lemeshow test (χ = 5.014, p = 0.756), with excellent net benefit shown by decision curve analysis. Our findings indicate a high infection rate in DF patients, mainly caused by Gram-positive cocci. The nomogram incorporating age, CRP, Wagner grade, LEAD, and PN parameters enables rapid DFIs screening, facilitating timely antibiotic initiation through early infection detection to enhance clinical management.

摘要

本研究旨在调查糖尿病足感染(DFIs)中致病微生物的分布情况,并开发一种列线图以预测DFIs。该研究纳入了2020年11月至2024年11月在河南大学淮河医院住院的136例糖尿病足(DF)患者,其中86例(63.23%)确诊感染。感染主要由革兰氏阳性球菌(54.65%)和革兰氏阴性杆菌(43.02%)引起。列线图纳入了年龄、C反应蛋白(CRP)、瓦格纳分级、下肢动脉疾病(LEAD)和周围神经病变(PN)。该预测模型具有强大的区分能力,内部交叉验证稳定性下曲线下面积(AUC)为0.803(95%置信区间(CI)0.735 - 0.878)(AUC = 0.804)。Hosmer-Lemeshow检验证实了拟合优度(χ = 5.014,p = 0.756),决策曲线分析显示净效益良好。我们的研究结果表明DF患者感染率高,主要由革兰氏阳性球菌引起。纳入年龄、CRP、瓦格纳分级、LEAD和PN参数的列线图能够快速筛查DFIs,通过早期感染检测促进及时使用抗生素,以加强临床管理。

相似文献

1
Characterization of pathogenic microorganisms in diabetic foot infections and development of a risk prediction model.糖尿病足感染中致病微生物的特征分析及风险预测模型的建立
Sci Rep. 2025 Jul 2;15(1):23553. doi: 10.1038/s41598-025-07092-5.
2
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
3
LASSO regression-based nomogram for distinguishing nontuberculous mycobacterial pulmonary disease from pulmonary tuberculosis: a clinical risk prediction model.基于LASSO回归的列线图用于区分非结核分枝杆菌肺病和肺结核:一种临床风险预测模型
Sci Rep. 2025 Jul 1;15(1):21099. doi: 10.1038/s41598-025-08456-7.
4
A novel nomogram for predicting osteoporosis with low back pain among the patients in Wenshan Zhuang and Miao Autonomous Prefecture of China.中国文山壮族苗族自治州患者中用于预测伴有腰痛的骨质疏松症的新型列线图。
Front Endocrinol (Lausanne). 2025 Jun 5;16:1535163. doi: 10.3389/fendo.2025.1535163. eCollection 2025.
5
The Development and Validation of a Nomogram for Predicting Sepsis Risk in Diabetic Patients with Urinary Tract Infection.预测糖尿病合并尿路感染患者脓毒症风险的列线图的开发与验证
Medicina (Kaunas). 2025 Jan 27;61(2):225. doi: 10.3390/medicina61020225.
6
Development and validation of a risk prediction model for meropenem-related thrombocytopenia in patients with pulmonary infection.肺部感染患者美罗培南相关血小板减少症风险预测模型的开发与验证
BMC Pharmacol Toxicol. 2025 Jul 1;26(1):127. doi: 10.1186/s40360-025-00962-8.
7
Topical antimicrobial agents for treating foot ulcers in people with diabetes.用于治疗糖尿病患者足部溃疡的局部抗菌剂。
Cochrane Database Syst Rev. 2017 Jun 14;6(6):CD011038. doi: 10.1002/14651858.CD011038.pub2.
8
Development and validation of a dynamic nomogram for predicting enteral nutrition feeding intolerance in patients with severe traumatic brain injury: An external validation study.用于预测重度创伤性脑损伤患者肠内营养喂养不耐受的动态列线图的开发与验证:一项外部验证研究
Medicine (Baltimore). 2025 Jun 27;104(26):e42993. doi: 10.1097/MD.0000000000042993.
9
Efficacy and validation of a clinical predictive model for chronic atrophic gastritis in patients: a multi-center retrospective analysis.患者慢性萎缩性胃炎临床预测模型的有效性及验证:一项多中心回顾性分析
Front Med (Lausanne). 2025 Jun 19;12:1570893. doi: 10.3389/fmed.2025.1570893. eCollection 2025.
10
Construction and validation of a risk prediction model for extensive abdominal aortic calcification in hypertensive patients aged 40 and above: a cross-sectional study based on the 2013-2014 NHANES database.40岁及以上高血压患者广泛性腹主动脉钙化风险预测模型的构建与验证:一项基于2013 - 2014年美国国家健康与营养检查调查(NHANES)数据库的横断面研究
BMC Cardiovasc Disord. 2025 Jul 4;25(1):462. doi: 10.1186/s12872-025-04912-4.

本文引用的文献

1
Unravelling the cardio-renal-metabolic-foot connection in people with diabetes-related foot ulceration: a narrative review.解析糖尿病相关足部溃疡患者的心脏-肾脏-代谢-足部关联:一项叙述性综述
Cardiovasc Diabetol. 2024 Dec 18;23(1):437. doi: 10.1186/s12933-024-02527-1.
2
The infected diabetic foot: Incidence and risk factors for dehiscence after surgery for diabetic foot infections.感染性糖尿病足:糖尿病足感染手术后的裂开发生率及危险因素。
Wound Repair Regen. 2025 Jan-Feb;33(1):e13235. doi: 10.1111/wrr.13235.
3
Emerging technologies for the management of diabetic foot ulceration: a review.
糖尿病足溃疡管理的新兴技术:综述
Front Clin Diabetes Healthc. 2024 Nov 12;5:1440209. doi: 10.3389/fcdhc.2024.1440209. eCollection 2024.
4
A systematic review of diabetic foot infections: pathogenesis, diagnosis, and management strategies.糖尿病足感染的系统评价:发病机制、诊断及管理策略
Front Clin Diabetes Healthc. 2024 Aug 6;5:1393309. doi: 10.3389/fcdhc.2024.1393309. eCollection 2024.
5
Distribution of multidrug-resistant bacterial infections in diabetic foot ulcers and risk factors for drug resistance: a retrospective analysis.糖尿病足溃疡患者中多重耐药菌感染的分布及耐药危险因素分析:一项回顾性研究
PeerJ. 2023 Oct 9;11:e16162. doi: 10.7717/peerj.16162. eCollection 2023.
6
IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023).国际糖尿病足工作组/美国感染病学会关于糖尿病相关足部感染的诊断和治疗指南(IWGDF/IDSA 2023)。
Diabetes Metab Res Rev. 2024 Mar;40(3):e3687. doi: 10.1002/dmrr.3687. Epub 2023 Oct 1.
7
Risk prediction models for diabetic foot ulcer development or amputation: a review of reviews.糖尿病足溃疡或截肢风险预测模型:系统评价综述。
J Foot Ankle Res. 2023 Mar 16;16(1):13. doi: 10.1186/s13047-023-00610-6.
8
Development and validation of a risk prediction model for the recurrence of foot ulcer in type 2 diabetes in China: A longitudinal cohort study based on a systematic review and meta-analysis.基于系统评价和荟萃分析的中国 2 型糖尿病患者足部溃疡复发风险预测模型的建立与验证:一项纵向队列研究。
Diabetes Metab Res Rev. 2023 May;39(4):e3616. doi: 10.1002/dmrr.3616. Epub 2023 Feb 4.
9
Predicting the Risk of Diabetic Foot Ulcers From Diabetics With Dysmetabolism: A Retrospective Clinical Trial.从代谢异常的糖尿病患者预测糖尿病足溃疡的风险:一项回顾性临床试验。
Front Endocrinol (Lausanne). 2022 Jul 12;13:929864. doi: 10.3389/fendo.2022.929864. eCollection 2022.
10
Diabetic foot infections: A microbiologic review.糖尿病足感染:微生物学综述。
Foot (Edinb). 2022 May;51:101877. doi: 10.1016/j.foot.2021.101877. Epub 2021 Oct 25.